Modulation of the gut microbiome and resistome by antibiotic use, but not by subsequent 2'-fucosyllactose intake, in adults with overweight or obesity. [PDF]
Vliex LMM +4 more
europepmc +1 more source
2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial. [PDF]
Kennedy JM +5 more
europepmc +1 more source
Aryl Hydrocarbon Receptor Deficiency Impairs Intestinal Barrier Development, While 2'-Fucosyllactose Reduces Paracellular Permeability in Caco-2 Cells. [PDF]
Madella AM +6 more
europepmc +1 more source
2'-Fucosyllactose Effects on Preterm Growth, Tolerance, and Neurobehavior: A Double-Blind, Randomized, Placebo-Controlled Pilot. [PDF]
Mezoff EA +7 more
europepmc +1 more source
Production of fucosyllactose with a fucosidase from Aspergillus niger
The interest on Human Milk Oligosaccharides (HMOs) has been increasing throughout the last years due to their reported beneficial effects on the infant’s nutrition.
Ruvalcaba Medrano, Marcela
core
The Effect of 2'-Fucosyllactose on Gut Health in Aged Mice. [PDF]
Jiang S +6 more
europepmc +1 more source
2'-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood. [PDF]
Kaur H +9 more
europepmc +1 more source
<i>Bifidobacterium longum</i> Subspecies <i>infantis</i> M63 Enhances the Colitis-Alleviating Effect of 2'-Fucosyllactose by Restoring Intestinal Barrier Function and Microbial Metabolism. [PDF]
Zhang H, Li X, Tan M, Bao Y, Jiang S.
europepmc +1 more source
Precision synbiotic intervention with 2'-fucosyllactose and infant-derived <i>Bifidobacterium</i> modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial. [PDF]
Chen K +15 more
europepmc +1 more source
Synbiotic effects of 2'-fucosyllactose and <i>Bifidobacterium longum</i> subsp. <i>infantis</i> M-63 in fermented human fecal communities. [PDF]
Mingat SX +7 more
europepmc +1 more source

